PMC:2222968 / 1245-1493
Annnotations
pmc-enju-pas
{"project":"pmc-enju-pas","denotations":[{"id":"T301","span":{"begin":0,"end":4},"obj":"NN"},{"id":"T302","span":{"begin":5,"end":14},"obj":"NN"},{"id":"T303","span":{"begin":15,"end":17},"obj":"IN"},{"id":"T304","span":{"begin":18,"end":22},"obj":"NN"},{"id":"T305","span":{"begin":23,"end":30},"obj":"VB"},{"id":"T306","span":{"begin":31,"end":36},"obj":"NN"},{"id":"T307","span":{"begin":37,"end":41},"obj":"NN"},{"id":"T308","span":{"begin":42,"end":51},"obj":"NN"},{"id":"T309","span":{"begin":51,"end":52},"obj":"-COMMA-"},{"id":"T310","span":{"begin":53,"end":65},"obj":"VB"},{"id":"T311","span":{"begin":66,"end":70},"obj":"IN"},{"id":"T312","span":{"begin":71,"end":82},"obj":"JJ"},{"id":"T313","span":{"begin":83,"end":93},"obj":"NN"},{"id":"T314","span":{"begin":94,"end":98},"obj":"WDT"},{"id":"T315","span":{"begin":99,"end":105},"obj":"VB"},{"id":"T316","span":{"begin":106,"end":110},"obj":"NN"},{"id":"T317","span":{"begin":111,"end":113},"obj":"CC"},{"id":"T318","span":{"begin":114,"end":119},"obj":"NN"},{"id":"T319","span":{"begin":120,"end":125},"obj":"MD"},{"id":"T320","span":{"begin":126,"end":133},"obj":"VB"},{"id":"T321","span":{"begin":134,"end":137},"obj":"JJ"},{"id":"T322","span":{"begin":138,"end":148},"obj":"JJ"},{"id":"T323","span":{"begin":149,"end":159},"obj":"NN"},{"id":"T324","span":{"begin":160,"end":172},"obj":"VB"},{"id":"T325","span":{"begin":173,"end":182},"obj":"NN"},{"id":"T326","span":{"begin":183,"end":192},"obj":"NN"},{"id":"T327","span":{"begin":193,"end":205},"obj":"RB"},{"id":"T328","span":{"begin":206,"end":208},"obj":"IN"},{"id":"T329","span":{"begin":209,"end":221},"obj":"JJ"},{"id":"T330","span":{"begin":222,"end":230},"obj":"NN"},{"id":"T331","span":{"begin":230,"end":231},"obj":"-COMMA-"},{"id":"T332","span":{"begin":232,"end":236},"obj":"JJ"},{"id":"T333","span":{"begin":237,"end":239},"obj":"IN"},{"id":"T334","span":{"begin":240,"end":247},"obj":"NN"}],"relations":[{"id":"R246","pred":"arg1Of","subj":"T302","obj":"T301"},{"id":"R247","pred":"arg1Of","subj":"T302","obj":"T303"},{"id":"R248","pred":"arg1Of","subj":"T302","obj":"T305"},{"id":"R249","pred":"arg1Of","subj":"T302","obj":"T310"},{"id":"R250","pred":"arg2Of","subj":"T304","obj":"T303"},{"id":"R251","pred":"arg1Of","subj":"T305","obj":"T309"},{"id":"R252","pred":"modOf","subj":"T305","obj":"T310"},{"id":"R253","pred":"arg2Of","subj":"T308","obj":"T305"},{"id":"R254","pred":"arg1Of","subj":"T308","obj":"T306"},{"id":"R255","pred":"arg1Of","subj":"T308","obj":"T307"},{"id":"R256","pred":"arg1Of","subj":"T313","obj":"T312"},{"id":"R257","pred":"arg1Of","subj":"T313","obj":"T314"},{"id":"R258","pred":"arg1Of","subj":"T313","obj":"T315"},{"id":"R259","pred":"arg1Of","subj":"T313","obj":"T319"},{"id":"R260","pred":"arg1Of","subj":"T313","obj":"T320"},{"id":"R261","pred":"arg1Of","subj":"T316","obj":"T317"},{"id":"R262","pred":"arg2Of","subj":"T317","obj":"T315"},{"id":"R263","pred":"arg2Of","subj":"T318","obj":"T317"},{"id":"R264","pred":"arg2Of","subj":"T320","obj":"T310"},{"id":"R265","pred":"arg1Of","subj":"T320","obj":"T311"},{"id":"R266","pred":"arg2Of","subj":"T320","obj":"T319"},{"id":"R267","pred":"arg1Of","subj":"T320","obj":"T328"},{"id":"R268","pred":"arg2Of","subj":"T323","obj":"T320"},{"id":"R269","pred":"arg1Of","subj":"T323","obj":"T321"},{"id":"R270","pred":"arg1Of","subj":"T323","obj":"T322"},{"id":"R271","pred":"arg1Of","subj":"T323","obj":"T324"},{"id":"R272","pred":"arg2Of","subj":"T326","obj":"T324"},{"id":"R273","pred":"arg1Of","subj":"T326","obj":"T325"},{"id":"R274","pred":"arg1Of","subj":"T328","obj":"T327"},{"id":"R275","pred":"arg2Of","subj":"T330","obj":"T328"},{"id":"R276","pred":"arg1Of","subj":"T330","obj":"T329"},{"id":"R277","pred":"arg1Of","subj":"T330","obj":"T331"},{"id":"R278","pred":"arg1Of","subj":"T330","obj":"T333"},{"id":"R279","pred":"arg1Of","subj":"T333","obj":"T332"},{"id":"R280","pred":"arg2Of","subj":"T334","obj":"T333"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
bionlp-st-ge-2016-spacy-parsed
{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T565","span":{"begin":0,"end":4},"obj":"NN"},{"id":"T566","span":{"begin":5,"end":14},"obj":"NN"},{"id":"T567","span":{"begin":15,"end":17},"obj":"IN"},{"id":"T568","span":{"begin":18,"end":22},"obj":"NNS"},{"id":"T569","span":{"begin":23,"end":30},"obj":"VBZ"},{"id":"T570","span":{"begin":31,"end":36},"obj":"NNP"},{"id":"T571","span":{"begin":37,"end":41},"obj":"NN"},{"id":"T572","span":{"begin":42,"end":51},"obj":"NN"},{"id":"T573","span":{"begin":51,"end":52},"obj":","},{"id":"T574","span":{"begin":53,"end":65},"obj":"VBG"},{"id":"T575","span":{"begin":66,"end":70},"obj":"IN"},{"id":"T576","span":{"begin":71,"end":82},"obj":"JJ"},{"id":"T577","span":{"begin":83,"end":93},"obj":"NNS"},{"id":"T578","span":{"begin":94,"end":98},"obj":"WDT"},{"id":"T579","span":{"begin":99,"end":105},"obj":"VBP"},{"id":"T580","span":{"begin":106,"end":110},"obj":"NN"},{"id":"T581","span":{"begin":111,"end":113},"obj":"CC"},{"id":"T582","span":{"begin":114,"end":119},"obj":"NN"},{"id":"T583","span":{"begin":120,"end":125},"obj":"MD"},{"id":"T584","span":{"begin":126,"end":133},"obj":"VB"},{"id":"T585","span":{"begin":134,"end":137},"obj":"JJ"},{"id":"T586","span":{"begin":138,"end":148},"obj":"JJ"},{"id":"T587","span":{"begin":149,"end":159},"obj":"NNS"},{"id":"T588","span":{"begin":160,"end":172},"obj":"VBG"},{"id":"T589","span":{"begin":173,"end":182},"obj":"NN"},{"id":"T590","span":{"begin":183,"end":192},"obj":"NN"},{"id":"T591","span":{"begin":193,"end":205},"obj":"RB"},{"id":"T592","span":{"begin":206,"end":208},"obj":"IN"},{"id":"T593","span":{"begin":209,"end":221},"obj":"JJ"},{"id":"T594","span":{"begin":222,"end":230},"obj":"NNS"},{"id":"T595","span":{"begin":230,"end":231},"obj":","},{"id":"T596","span":{"begin":232,"end":236},"obj":"JJ"},{"id":"T597","span":{"begin":237,"end":239},"obj":"IN"},{"id":"T598","span":{"begin":240,"end":247},"obj":"NN"},{"id":"T599","span":{"begin":247,"end":248},"obj":"."}],"relations":[{"id":"R485","pred":"compound","subj":"T565","obj":"T566"},{"id":"R486","pred":"nsubj","subj":"T566","obj":"T569"},{"id":"R487","pred":"prep","subj":"T567","obj":"T566"},{"id":"R488","pred":"pobj","subj":"T568","obj":"T567"},{"id":"R489","pred":"ROOT","subj":"T569","obj":"T569"},{"id":"R490","pred":"compound","subj":"T570","obj":"T572"},{"id":"R491","pred":"compound","subj":"T571","obj":"T572"},{"id":"R492","pred":"dobj","subj":"T572","obj":"T569"},{"id":"R493","pred":"punct","subj":"T573","obj":"T569"},{"id":"R494","pred":"advcl","subj":"T574","obj":"T569"},{"id":"R495","pred":"mark","subj":"T575","obj":"T584"},{"id":"R496","pred":"amod","subj":"T576","obj":"T577"},{"id":"R497","pred":"nsubj","subj":"T577","obj":"T584"},{"id":"R498","pred":"nsubj","subj":"T578","obj":"T579"},{"id":"R499","pred":"relcl","subj":"T579","obj":"T577"},{"id":"R500","pred":"dobj","subj":"T580","obj":"T579"},{"id":"R501","pred":"cc","subj":"T581","obj":"T580"},{"id":"R502","pred":"conj","subj":"T582","obj":"T580"},{"id":"R503","pred":"aux","subj":"T583","obj":"T584"},{"id":"R504","pred":"ccomp","subj":"T584","obj":"T574"},{"id":"R505","pred":"amod","subj":"T585","obj":"T587"},{"id":"R506","pred":"amod","subj":"T586","obj":"T587"},{"id":"R507","pred":"dobj","subj":"T587","obj":"T584"},{"id":"R508","pred":"advcl","subj":"T588","obj":"T584"},{"id":"R509","pred":"compound","subj":"T589","obj":"T590"},{"id":"R510","pred":"dobj","subj":"T590","obj":"T588"},{"id":"R511","pred":"advmod","subj":"T591","obj":"T592"},{"id":"R512","pred":"prep","subj":"T592","obj":"T590"},{"id":"R513","pred":"amod","subj":"T593","obj":"T594"},{"id":"R514","pred":"pobj","subj":"T594","obj":"T592"},{"id":"R515","pred":"punct","subj":"T595","obj":"T594"},{"id":"R516","pred":"amod","subj":"T596","obj":"T597"},{"id":"R517","pred":"prep","subj":"T597","obj":"T594"},{"id":"R518","pred":"pobj","subj":"T598","obj":"T597"},{"id":"R519","pred":"punct","subj":"T599","obj":"T569"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T76","span":{"begin":173,"end":192},"obj":"http://purl.obolibrary.org/obo/GO_0002507"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
GO-MF
{"project":"GO-MF","denotations":[{"id":"T632","span":{"begin":0,"end":4},"obj":"http://purl.obolibrary.org/obo/GO_0005136"},{"id":"T633","span":{"begin":106,"end":110},"obj":"http://purl.obolibrary.org/obo/GO_0005136"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
GO-CC
{"project":"GO-CC","denotations":[{"id":"T639","span":{"begin":37,"end":41},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
sentences
{"project":"sentences","denotations":[{"id":"T66","span":{"begin":0,"end":248},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":248},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
ICD10
{"project":"ICD10","denotations":[{"id":"T630","span":{"begin":240,"end":247},"obj":"http://purl.bioontology.org/ontology/ICD10/T78.4"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
events-check-again
{"project":"events-check-again","denotations":[{"id":"T777","span":{"begin":0,"end":4},"obj":"Protein"},{"id":"T778","span":{"begin":99,"end":105},"obj":"Regulation"},{"id":"T779","span":{"begin":99,"end":105},"obj":"Regulation"},{"id":"T780","span":{"begin":106,"end":110},"obj":"Protein"},{"id":"T781","span":{"begin":114,"end":119},"obj":"Protein"}],"relations":[{"id":"R607","pred":"themeOf","subj":"T780","obj":"T778"},{"id":"R608","pred":"themeOf","subj":"T781","obj":"T779"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
bionlp-st-ge-2016-reference-tees
{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T666","span":{"begin":0,"end":4},"obj":"Protein"},{"id":"T667","span":{"begin":99,"end":110},"obj":"Protein"},{"id":"T668","span":{"begin":114,"end":119},"obj":"Protein"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
bionlp-st-ge-2016-reference
{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T81","span":{"begin":99,"end":105},"obj":"Regulation"},{"id":"T82","span":{"begin":99,"end":105},"obj":"Regulation"},{"id":"T95","span":{"begin":0,"end":4},"obj":"Protein"},{"id":"T96","span":{"begin":106,"end":110},"obj":"Protein"},{"id":"T97","span":{"begin":114,"end":119},"obj":"Protein"}],"relations":[{"id":"R627","pred":"themeOf","subj":"T96","obj":"T81"},{"id":"R628","pred":"themeOf","subj":"T97","obj":"T82"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
bionlp-st-ge-2016-uniprot
{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T349","span":{"begin":0,"end":4},"obj":"P05112"},{"id":"T350","span":{"begin":106,"end":110},"obj":"P05112"},{"id":"T351","span":{"begin":114,"end":119},"obj":"P23771"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}
test2
{"project":"test2","denotations":[{"id":"T53","span":{"begin":0,"end":4},"obj":"Protein"},{"id":"T54","span":{"begin":99,"end":105},"obj":"Binding"},{"id":"T55","span":{"begin":106,"end":110},"obj":"Protein"},{"id":"T56","span":{"begin":114,"end":119},"obj":"Protein"}],"relations":[{"id":"R36","pred":"themeOf","subj":"T53","obj":"T54"},{"id":"R37","pred":"themeOf","subj":"T55","obj":"T54"},{"id":"R38","pred":"themeOf","subj":"T56","obj":"T54"}],"text":"IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy."}